Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Identifying cancer-specific vulnerabilities is crucial for developing targeted therapies.
• Adenosine deaminase acting on RNA 1 (ADAR1) is implicated in various cellular processes.

Purpose of the Study:

• To identify novel cancer therapeutic targets through systematic exploration of cancer cell vulnerabilities.
• To investigate the role of ADAR1 in cancer cell survival and the mechanisms underlying its essentiality.

Main Methods:

• Genome-scale loss-of-function screens were employed to identify essential genes in cancer cell lines.
• Analysis of gene expression, specifically interferon-stimulated genes and double-stranded RNA sensors like protein kinase R (PKR).
• Functional assays involving gene inactivation, mutation, and overexpression to assess cell lethality and signaling pathway activation.

Main Results:

• ADAR1 was identified as an essential gene for the survival of a subset of cancer cell lines.
• ADAR1-deficient cells exhibited increased expression of interferon-stimulated genes and activation of the PKR pathway.
• Disruption of PKR signaling or specific ADAR1 functions partially rescued cell lethality, indicating a role for both catalytic and non-enzymatic functions of ADAR1.

Conclusions:

• ADAR1 is a critical survival factor in a subset of cancers.
• ADAR1's function, including its non-enzymatic roles, is important in preventing PKR-mediated cell death.
• ADAR1 represents a promising therapeutic target for specific cancer types.